These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 31109698)

  • 21. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count.
    Li YL; Shi ZH; Wang X; Gu KS; Zhai ZM
    BMC Cancer; 2019 Nov; 19(1):1049. PubMed ID: 31694577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD163
    Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
    Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
    Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.
    Chen XY; Thike AA; Md Nasir ND; Koh VCY; Bay BH; Tan PH
    Virchows Arch; 2020 Jun; 476(6):825-833. PubMed ID: 31897820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
    Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
    Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
    Sugimura K; Miyata H; Tanaka K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    J Surg Oncol; 2015 May; 111(6):752-9. PubMed ID: 25752960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma.
    Handl M; Hermanova M; Hotarkova S; Jarkovsky J; Mudry P; Shatokhina T; Vesela M; Sterba J; Zambo I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):54-60. PubMed ID: 29170560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
    Allison E; Edirimanne S; Matthews J; Fuller SJ
    Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
    Kong LQ; Zhu XD; Xu HX; Zhang JB; Lu L; Wang WQ; Zhang QB; Wu WZ; Wang L; Fan J; Tang ZY; Sun HC
    PLoS One; 2013; 8(3):e59771. PubMed ID: 23555776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M2-like macrophage polarization in high lactic acid-producing head and neck cancer.
    Ohashi T; Aoki M; Tomita H; Akazawa T; Sato K; Kuze B; Mizuta K; Hara A; Nagaoka H; Inoue N; Ito Y
    Cancer Sci; 2017 Jun; 108(6):1128-1134. PubMed ID: 28370718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas.
    Agarbati S; Mascitti M; Paolucci E; Togni L; Santarelli A; Rubini C; Fazioli F
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):359-365. PubMed ID: 32842026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining UBR5 and CD163
    Wang C; Hong T; Wang Y; Peng G; Yu Y; Zhang J; Zhuo D; Zheng J; Ma X; Cui X
    Cancer Immunol Immunother; 2021 Oct; 70(10):2925-2935. PubMed ID: 33710368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study.
    Dawoud MM; Abd El Samie Aiad H; Kasem NS; El Khouly EA; Al-Sharaky DR
    J Immunoassay Immunochem; 2024 Jul; 45(4):342-361. PubMed ID: 38815282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
    Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE
    Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
    Abd Allah MYY; Fahmi MW; El-Ashwah S
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
    Tan KL; Scott DW; Hong F; Kahl BS; Fisher RI; Bartlett NL; Advani RH; Buckstein R; Rimsza LM; Connors JM; Steidl C; Gordon LI; Horning SJ; Gascoyne RD
    Blood; 2012 Oct; 120(16):3280-7. PubMed ID: 22948049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
    Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
    J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.